Clinical Trials Logo

Clinical Trial Summary

The investigators goal is to conduct a pilot randomized controlled trial (RCT) whose purpose is to determine the feasibility of a randomized trial designed to determine if either inhaled beclomethasone or a combination of inhaled beclomethasone/salbutamol (Clenil Compositum) are superior to placebo in treating pre-school aged children with an acute wheezing episode.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02319564
Study type Interventional
Source University of Calgary
Contact
Status Withdrawn
Phase Phase 4
Start date April 2016
Completion date October 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT01868932 - Treating Wheezing in Children With Hypertonic Saline (TWICS) Phase 2
Completed NCT02743663 - The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Recruiting NCT02496468 - Pediatric Arm of DZL All Age Asthma Cohort